Yongping Yu
Research Interests
Yongping Yu has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Wenteng Chen
College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China
3 shared publications Bo Peng
College of Pharmaceutical Sciences
2 shared publicationsZhenying Wu
College of Pharmaceutical Sciences
2 shared publicationsDanzhi Ying
College of Pharmaceutical Sciences
1 shared publicationDi Liu
School of Information Management, Xinjiang University of Finance and Economics, Urumqi, Xinjiang 830012, P. R.China
1 shared publication- Dongli Pan
Department of Medical Microbiology and Parasitology, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
1 shared publication
Latest Publications
- 22 October 2025
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 90 (43) , 15150-15161
Divergent Synthesis of Alkenyl Sulfur Ylides and Sulfides through Base-Controlled Cascade Reactions of Prop-2-ynylsulfonium Salts and α,α-Dicyanoalkenes
A base-controlled divergent reaction between α,α-dicyanoalkenes and prop-2-ynylsulfonium salts is described. Treatment of Cs2CO3 enables selective transformation of various α,α-dicyanoalkenes and prop-2-ynylsulfonium salts into 2,3-dienyl sulfur ylides through a 1,3-intramolecular rearrangement pathway. In contrast, when CsOAc is employed in the presence of AcOH, the reaction proceeds through a protonation-demethylation sequence pathway to afford 1,4-dienyl sulfides. The chemistry features mild reaction conditions, broad substrate compatibility, and scalability for practical applications.
- 22 October 2025
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 90 (43) , 15150-15161
Divergent Synthesis of Alkenyl Sulfur Ylides and Sulfides through Base-Controlled Cascade Reactions of Prop-2-ynylsulfonium Salts and α,α-Dicyanoalkenes
A base-controlled divergent reaction between α,α-dicyanoalkenes and prop-2-ynylsulfonium salts is described. Treatment of Cs2CO3 enables selective transformation of various α,α-dicyanoalkenes and prop-2-ynylsulfonium salts into 2,3-dienyl sulfur ylides through a 1,3-intramolecular rearrangement pathway. In contrast, when CsOAc is employed in the presence of AcOH, the reaction proceeds through a protonation-demethylation sequence pathway to afford 1,4-dienyl sulfides. The chemistry features mild reaction conditions, broad substrate compatibility, and scalability for practical applications.
- 18 June 2025
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (13) , 13393-13407
Design and Synthesis of PAN Endonuclease Inhibitors through Spirocyclization Strategy against Influenza A Virus
The PAN endonuclease inhibitor baloxavir marked a significant advancement in influenza treatment. Herein, we reported the development of PAN inhibitors through structural simplification of baloxavir̀s tricyclic system coupled with strategic incorporation of a spirocyclic architecture, which aims to construct a new metal-binding pharmacophore with distinct three-dimensional features. Lead 39-(S) was identified and exhibited nanomolar potency against influenza virus polymerase complexes (IC50 = 17.4 nM), which was mechanistically attributed to PAN endonuclease inhibition. Furthermore, 39-(S) demonstrated robust antiviral activities against multiple current and different influenza virus strains while showing minimal cytotoxicity in MDCK cells, ensuring an exceptional selectivity index of more than 2.4 × 105 during antiviral treatment. Additionally, both 39-(S) and its prodrug 41 significantly suppressed viral replication in an A/WSN/33 infected mouse model with efficacy profiles remarkably comparable to those of baloxavir. Collectively, 39-(S) emerges as a potent PAN inhibitor with the potential for further development.
- 18 June 2025
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (13) , 13393-13407
Design and Synthesis of PAN Endonuclease Inhibitors through Spirocyclization Strategy against Influenza A Virus
The PAN endonuclease inhibitor baloxavir marked a significant advancement in influenza treatment. Herein, we reported the development of PAN inhibitors through structural simplification of baloxavir̀s tricyclic system coupled with strategic incorporation of a spirocyclic architecture, which aims to construct a new metal-binding pharmacophore with distinct three-dimensional features. Lead 39-(S) was identified and exhibited nanomolar potency against influenza virus polymerase complexes (IC50 = 17.4 nM), which was mechanistically attributed to PAN endonuclease inhibition. Furthermore, 39-(S) demonstrated robust antiviral activities against multiple current and different influenza virus strains while showing minimal cytotoxicity in MDCK cells, ensuring an exceptional selectivity index of more than 2.4 × 105 during antiviral treatment. Additionally, both 39-(S) and its prodrug 41 significantly suppressed viral replication in an A/WSN/33 infected mouse model with efficacy profiles remarkably comparable to those of baloxavir. Collectively, 39-(S) emerges as a potent PAN inhibitor with the potential for further development.
- 18 June 2025
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (13) , 13321-13334
Discovery of Novel Piperazinone-Fused Hydroxypyridinones Inhibiting Herpes Simplex Virus Gene Transcription and Viral Replication
Herpes simplex virus poses a significant public health burden, necessitating the development of alternative therapeutic strategies to combat infection while addressing the growing challenge of drug resistance observed with conventional nucleoside antivirals. Herein, we conducted a mixture-based library screening of an in-house small molecule library, leading to the identification of a novel piperazinone-fused hydroxypyridinone scaffold A. Structure-activity relationship studies initiated from hit A11 culminated in the development of lead A50, which exhibited a significant enhancement in the inhibitory activity against luc-HSV-1. Notably, A50 demonstrated good antiviral efficacy against both acyclovir-sensitive and -resistant HSV strains while showing weak cytotoxicity. Preliminary mechanistic investigations revealed that A50 inhibited viral gene transcription at a very early stage and also inhibited a later stage of viral replication, distinct from acyclovir. Moreover, administration of A50 significantly suppressed viral replication in an HSV-1 strain KOS-infected mouse model with no observable toxicity, offering a promising pathway for further development.
- 18 June 2025
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (13) , 13321-13334
Discovery of Novel Piperazinone-Fused Hydroxypyridinones Inhibiting Herpes Simplex Virus Gene Transcription and Viral Replication
Herpes simplex virus poses a significant public health burden, necessitating the development of alternative therapeutic strategies to combat infection while addressing the growing challenge of drug resistance observed with conventional nucleoside antivirals. Herein, we conducted a mixture-based library screening of an in-house small molecule library, leading to the identification of a novel piperazinone-fused hydroxypyridinone scaffold A. Structure-activity relationship studies initiated from hit A11 culminated in the development of lead A50, which exhibited a significant enhancement in the inhibitory activity against luc-HSV-1. Notably, A50 demonstrated good antiviral efficacy against both acyclovir-sensitive and -resistant HSV strains while showing weak cytotoxicity. Preliminary mechanistic investigations revealed that A50 inhibited viral gene transcription at a very early stage and also inhibited a later stage of viral replication, distinct from acyclovir. Moreover, administration of A50 significantly suppressed viral replication in an HSV-1 strain KOS-infected mouse model with no observable toxicity, offering a promising pathway for further development.
- 30 December 2019
- Published by World Scientific Pub Co Pte Ltd in International Journal of Modern Physics B
- Vol. 33 (32) , 1950387
Find modules in signed networks based on modularity optimization
The signed network depicts individual cooperative or hostile attitude in a system. It is very important to study the characteristics of complex networks and predict individual attitudes by analyzing the attitudes of individuals and their neighbors, which can divide individuals into different modules or communities. To detect the modules in signed networks, first, a modularity function for signed networks is utilized on the basis of the existing modularity function. Then, a new module detection algorithm for signed networks has also been put forward, which has high efficiency. Finally, the algorithm has been applied on both artificial and real networks. The results show that the number of modules given by our proposed algorithm is consistent with that of the number of actual modules.
- 30 December 2019
- Published by World Scientific Pub Co Pte Ltd in International Journal of Modern Physics B
- Vol. 33 (32) , 1950387
Find modules in signed networks based on modularity optimization
The signed network depicts individual cooperative or hostile attitude in a system. It is very important to study the characteristics of complex networks and predict individual attitudes by analyzing the attitudes of individuals and their neighbors, which can divide individuals into different modules or communities. To detect the modules in signed networks, first, a modularity function for signed networks is utilized on the basis of the existing modularity function. Then, a new module detection algorithm for signed networks has also been put forward, which has high efficiency. Finally, the algorithm has been applied on both artificial and real networks. The results show that the number of modules given by our proposed algorithm is consistent with that of the number of actual modules.